FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129126919> ?p ?o ?g. }

• W2129126919 endingPage "789" @default.
• W2129126919 startingPage "779" @default.
• W2129126919 abstract "Preclinical and clinical studies have shown beneficial effects of infusions of apolipoprotein A-I (ApoA-I) on atherosclerosis. ApoA-I is also a target for myeloperoxidase-mediated oxidation, leading in vitro to a loss of its ability to promote ATP-binding cassette transporter A1-dependent macrophage cholesterol efflux. Therefore, we hypothesized that myeloperoxidase-mediated ApoA-I oxidation would impair its promotion of reverse cholesterol transport in vivo and the beneficial effects on atherosclerotic plaques.ApoA-I(-/-) or apolipoprotein E-deficient mice were subcutaneously injected with native human ApoA-I, oxidized human ApoA-I (myeloperoxidase/hydrogen peroxide/chloride treated), or carrier. Although early postinjection (8 hours) levels of total ApoA-I in plasma were similar for native versus oxidized human ApoA-I, native ApoA-I primarily resided within the high-density lipoprotein fraction, whereas the majority of oxidized human ApoA-I was highly cross-linked and not high-density lipoprotein particle associated, consistent with impaired ATP-binding cassette transporter A1 interaction. In ApoA-I(-/-) mice, ApoA-I oxidation significantly impaired reverse cholesterol transport in vivo. In advanced aortic root atherosclerotic plaques of apolipoprotein E-deficient mice, native ApoA-I injections led to significant decreases in lipid content, macrophage number, and an increase in collagen content; in contrast, oxidized human ApoA-I failed to mediate these changes. The decrease in plaque macrophages with native ApoA-I was accompanied by significant induction of their chemokine receptor CCR7. Furthermore, only native ApoA-I injections led to a significant reduction of inflammatory M1 and increase in anti-inflammatory M2 macrophage markers in the plaques.Myeloperoxidase-mediated oxidation renders ApoA-I dysfunctional and unable to (1) promote reverse cholesterol transport, (2) mediate beneficial changes in the composition of atherosclerotic plaques, and (3) pacify the inflammatory status of plaque macrophages." @default.
• W2129126919 created "2016-06-24" @default.
• W2129126919 creator A5000039901 @default.
• W2129126919 creator A5002512182 @default.
• W2129126919 creator A5010932690 @default.
• W2129126919 creator A5015450319 @default.
• W2129126919 creator A5023886360 @default.
• W2129126919 creator A5026798454 @default.
• W2129126919 creator A5028095570 @default.
• W2129126919 creator A5036877016 @default.
• W2129126919 creator A5040647937 @default.
• W2129126919 creator A5055262419 @default.
• W2129126919 creator A5065965634 @default.
• W2129126919 creator A5066313762 @default.
• W2129126919 creator A5075365849 @default.
• W2129126919 creator A5076897207 @default.
• W2129126919 creator A5087677120 @default.
• W2129126919 creator A5088448170 @default.
• W2129126919 date "2014-04-01" @default.
• W2129126919 modified "2023-10-06" @default.
• W2129126919 title "Effects of Native and Myeloperoxidase-Modified Apolipoprotein A-I on Reverse Cholesterol Transport and Atherosclerosis in Mice" @default.
• W2129126919 cites W1516536249 @default.
• W2129126919 cites W1552425692 @default.
• W2129126919 cites W1683923016 @default.
• W2129126919 cites W1973014196 @default.
• W2129126919 cites W1973858093 @default.
• W2129126919 cites W1981310416 @default.
• W2129126919 cites W1996105698 @default.
• W2129126919 cites W2000857749 @default.
• W2129126919 cites W2020769052 @default.
• W2129126919 cites W2021518309 @default.
• W2129126919 cites W2031047943 @default.
• W2129126919 cites W2033102824 @default.
• W2129126919 cites W2036346955 @default.
• W2129126919 cites W2048481833 @default.
• W2129126919 cites W2048760408 @default.
• W2129126919 cites W2050846920 @default.
• W2129126919 cites W2051551756 @default.
• W2129126919 cites W2064255959 @default.
• W2129126919 cites W2066776235 @default.
• W2129126919 cites W2071884718 @default.
• W2129126919 cites W2093634680 @default.
• W2129126919 cites W2095507444 @default.
• W2129126919 cites W2100748836 @default.
• W2129126919 cites W2101975847 @default.
• W2129126919 cites W2110960044 @default.
• W2129126919 cites W2110997510 @default.
• W2129126919 cites W2118825330 @default.
• W2129126919 cites W2127427274 @default.
• W2129126919 cites W2133990668 @default.
• W2129126919 cites W2141409038 @default.
• W2129126919 cites W2141554996 @default.
• W2129126919 cites W2143353089 @default.
• W2129126919 cites W2143967889 @default.
• W2129126919 cites W2145813488 @default.
• W2129126919 cites W2151074227 @default.
• W2129126919 cites W2152561082 @default.
• W2129126919 cites W2156430718 @default.
• W2129126919 cites W2161279645 @default.
• W2129126919 cites W2162162221 @default.
• W2129126919 cites W2168964544 @default.
• W2129126919 cites W2169830111 @default.
• W2129126919 cites W2170767442 @default.
• W2129126919 cites W2186623609 @default.
• W2129126919 cites W2410405995 @default.
• W2129126919 cites W3590417 @default.
• W2129126919 cites W4230038264 @default.
• W2129126919 doi "https://doi.org/10.1161/atvbaha.113.303044" @default.
• W2129126919 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3966977" @default.
• W2129126919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24407029" @default.
• W2129126919 hasPublicationYear "2014" @default.
• W2129126919 type Work @default.
• W2129126919 sameAs 2129126919 @default.
• W2129126919 citedByCount "119" @default.
• W2129126919 countsByYear W21291269192014 @default.
• W2129126919 countsByYear W21291269192015 @default.
• W2129126919 countsByYear W21291269192016 @default.
• W2129126919 countsByYear W21291269192017 @default.
• W2129126919 countsByYear W21291269192018 @default.
• W2129126919 countsByYear W21291269192019 @default.
• W2129126919 countsByYear W21291269192020 @default.
• W2129126919 countsByYear W21291269192021 @default.
• W2129126919 countsByYear W21291269192022 @default.
• W2129126919 countsByYear W21291269192023 @default.
• W2129126919 crossrefType "journal-article" @default.
• W2129126919 hasAuthorship W2129126919A5000039901 @default.
• W2129126919 hasAuthorship W2129126919A5002512182 @default.
• W2129126919 hasAuthorship W2129126919A5010932690 @default.
• W2129126919 hasAuthorship W2129126919A5015450319 @default.
• W2129126919 hasAuthorship W2129126919A5023886360 @default.
• W2129126919 hasAuthorship W2129126919A5026798454 @default.
• W2129126919 hasAuthorship W2129126919A5028095570 @default.
• W2129126919 hasAuthorship W2129126919A5036877016 @default.
• W2129126919 hasAuthorship W2129126919A5040647937 @default.
• W2129126919 hasAuthorship W2129126919A5055262419 @default.
• W2129126919 hasAuthorship W2129126919A5065965634 @default.
• W2129126919 hasAuthorship W2129126919A5066313762 @default.
• W2129126919 hasAuthorship W2129126919A5075365849 @default.

• next